UBS AG (NYSE:UBS) was upgraded by analysts at Rafferty Capital Markets from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday,TheFlyOnTheWall.com reports. UBS AG (NYSE:UBS) net profit margin is 25.30% and weekly performance is -3.27%. On last trading day company shares ended up $19.79. Analysts mean target price for the company is $21.18. UBS AG (NYSE:UBS) distance from 50-day simple moving average (SMA50) is -3.74%.
Merck & Co., Inc and Endocyte, Inc. (NASDAQ:ECYT), announced the withdrawal of conditional marketing authorization applications (CMA) from the European Medicines Agency (EMA) for vintafolide and companion imaging components, imaging agent etarfolatide and intravenous (IV) folic acid, for the treatment of adult patients with folate receptor-positive, platinum-resistant ovarian cancer, in combination with pegylated liposomal doxorubicin (PLD). Endocyte, Inc. (NASDAQ:ECYT) shares fell -0.46% in last trading session and ended the day on $6.49. Its return on assets is -10.30%. Endocyte, Inc. (NASDAQ:ECYT) quarterly performance is -57.97%.
Google Inc (NASDAQ:GOOGL) subsidiary YouTube has apparently reached a deal to acquire video-game streaming company Twitch for over $1 billion. Twitch lets Xbox and PlayStation 4 gamers live-stream their gameplay to thousands of viewers at the same time. Recently, over 1 million people teamed up on Twitch to beat a Pokemon game after 390 hours of playing. Google Inc (NASDAQ:GOOGL) shares moved up 1.99% in last trading session and was closed at $538.83, while trading in range of $525.66- $539.35. Google Inc (NASDAQ:GOOGL) year to date (YTD) performance is -3.94%.
Google Inc. (NASDAQ:GOOG) is in talks to acquire the video game streaming service – Twitch, and have later plans to merge it with YouTube. According to new rumor, The video game streaming service, Twitch and YouTube might emerge as Google has offered over $1 billion to acquire the startup. Google Inc (NASDAQ:GOOG) ended the last trading day at $528.86. Company weekly volatility is calculated as 1.59 %. Google Inc (NASDAQ:GOOG) showed a positive weekly performance of -0.20%.
On May 12, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) provided a corporate update and reported financial results for the first quarter ended March 31, 2014. The company’s first quarter revenues totaled $6.8 million, including $2.9 million in net product sales of BELVIQ, of which $2.7 million represented 31.5% of Eisai’s net product sales and $0.2 million related to redemptions of the 15-day free voucher. Net loss was $25.3 million, or $0.12 per share. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) net profit margin is -30.20% and weekly performance is -4.82%. On last trading day company shares ended up $6.51. Analysts mean target price for the company is $7.83. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) distance from 50-day simple moving average (SMA50) is 0.79%.
Leave a Reply